Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The restructuring aims to create synergies across the business and strengthen capital structure
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
These re-agent and diagnostic test kits come with 99.7% accuracy
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
The company disclosed that several employees of a subsidiary had their business email addresses stolen
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Subscribe To Our Newsletter & Stay Updated
